Skip to content
healthcare.dev

ATOMOXETINE

NDC 82619-120, atomoxetine, capsule, from Creekwood Pharmaceuticals LLC.

Product NDC
82619-120
Status
Listed
Labeler
Creekwood Pharmaceuticals LLC
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA218875
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/82619-120 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ATOMOXETINE HYDROCHLORIDE80 mg/1

Pharmacologic classes

Norepinephrine Reuptake Inhibitor [EPC]; Norepinephrine Uptake Inhibitors [MoA]

Package NDCNDC-11Package
82619-120-018261901200130 CAPSULE in 1 BOTTLE (82619-120-01)
82619-120-02826190120021000 CAPSULE in 1 BOTTLE (82619-120-02)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/9b757805-eabf-4301-85be-7a3e38f6b187

Use it

Look up 82619-120 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/82619-120 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 82619-120. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.